phenobarbital will lower the level or impact of eltrombopag by affecting hepatic enzyme CYP2C9/10 metabolism. Use Caution/Watch.Keep away from; coadministration with CYP3A inducers may well result in diminished plasma concentrations of elvitegravir and/or maybe a concomitantly administered protease inhibitor and lead to loss of therapeutic effect a